Tag: <span>mFLUSIVA</span>

Breakthroughs

FDA Approves mFlusiva: The First mRNA Flu Vaccine for Adults 50 and Older

FDA Approves mFlusiva, the First mRNA Flu Vaccine, for Adults 50 and Older The United States Food and Drug Administration (FDA) has approved mFlusiva (mRNA-1010),...

Breakthroughs

FDA Approves First mRNA Flu Vaccine: What Older Adults Need to Know for the 2026-27 Flu Season

The U.S. Food and Drug Administration (FDA) has approved mFLUSIVA, the first mRNA-based influenza vaccine, for adults aged 50 and older — just in time...